2025-06-23 05:25:19
Latest Post
Zen Technologies Ltd announces strategic acquisition of majority stake in TISA Aerospace Private Limited
NLC India Renewables Ltd receives LoA from TNGECL for 3 BESS projects
NTPC Ltd commissions last part capacity of 52 MW of 245 MW Nokh Solar PV Project
Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
Ultra-mega Order Propels Bajel Projects' Contribution to India's Power Sector
Stock Report
Morepen Laboratories Ltd consolidated Q4 FY2024-25 net profit lower at Rs. 20.31 crores
Posted On : 2025-05-12 19:30:21( TIMEZONE : IST )
Morepen Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 470.4647 crores during the period ended March 31, 2025 as compared to Rs. 458.1176 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 20.3104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 26.6885 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 0.35 for the period ended March 31, 2025 as compared to Rs. 0.49 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 470.4647 crs | ₹458.1176 crs |  2.70% |
| Net Profit | ₹20.3104 crs | ₹26.6885 crs |  -23.90% |
| EPS | ₹0.35 | ₹0.49 | -28.57% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 470.4647 crores during the period ended March 31, 2025 as compared to Rs.427.3165 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.20.3104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.28.7410 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.0.35 for the period ended March 31, 2025 as compared to Rs.0.54 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 470.4647 crs | ₹427.3165 crs | 10.10% |
| Net Profit | ₹20.3104 crs | ₹28.7410 crs | -29.33% |
| EPS | ₹0.35 | ₹0.54 | -35.19% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.1829.9395 crores during the Financial Year ended March 31, 2025 as compared to Rs.1704.4033 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.118.0154 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.96.6203 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.2.20 for the Financial Year ended March 31, 2025 as compared to Rs.1.88 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹1829.9395 crs | ₹1704.4033 crs | 7.37% |
| Net Profit | ₹118.0154 crs | ₹96.6203 crs | 22.14% |
| EPS | ₹2.20 | ₹1.88 | 17.02% |
Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 60.38 as compared to the previous close of Rs. 56.23. The total number of shares traded during the day was 353254 in over 1393 trades.
The stock hit an intraday high of Rs. 60.65 and intraday low of 59.28. The net turnover during the day was Rs. 21214361.00.
